high dose methotrexat liver toxicity
نویسندگان
چکیده
introduction : methotrexate (mtx) is an anti folate drug that used in malignant and non malignant patients. the usage of high dose methotrexate was limited to patients with: osteogenic sarcoma, ewing sarcoma and lymphoma. the aim this study was to determine the toxicity or side effects of very high dose methotrexate (8-10 gr/m 2 /cycle). this study is the first study in iranian patients and one of few study in world wide with this dosage and number of patients. patients and methods: in a prospective study on all patients with osteogenic sarcoma, ewing sarcoma , and lymphoma that candidate for high dose mtx (mean total dosage was 27 gr/m 2 /case without any underlying disease, and after full physical examination and performing necessary paraclinical tests (na, k, bun, cr, uric acid, ast, alt, bilirubin, and ecg entered and information was filled for all of them prior and after the every cycle. the follow up visit include: repeated physical examination and duration of its was at least 6 months. results: there were 102 cases, 60 cases were male (58.8%), 42 female (41.2%), median age was 19.5 (5-80), osteogenic sarcoma and ewing sarcoma 87 cases (49/male and 38/female), 15 cases were lymphoma (11/male, 4/female). total course of mtx therapy was 273 (median courses were 2.67/patient). our result revealed: abdominal pain due to hepatomrgally was not obsereved, rising in bilirubin and alkaline phosphetase were not observed, but rising in ast and alt were the most common liver toxicity due to high dose mtx and detail were: this toxicity was in 23 cases (46.9%) [11/men (18.3%) and 12/female (28.6%)] respectively. the maximum toxicity was grade 2 toxicity according to nci criteria. all of them resolved spontaneously without any specific management and treatment except watch and wait. conclusion: this study revealed that the usage of very high dose methotrexate had liver toxicity but these toxicities were limited to abnormal ast and alt. all of these toxicities were transient and resolved without any scar on liver function after cessation of therapy. after at least 6 months follow up we didn’t see any abnormality.
منابع مشابه
Identification of structural alerts for liver and kidney toxicity using repeated dose toxicity data
BACKGROUND The potential for a compound to cause hepatotoxicity and nephrotoxicity is a matter of extreme interest for human health risk assessment. To assess liver and kidney toxicity, repeated-dose toxicity (RDT) studies are conducted mainly on rodents. However, these tests are expensive, time-consuming and require large numbers of animals. For early toxicity screening, in silico models can b...
متن کاملMedium and High-Dose Methotrexate-Induced Toxicity in Children with Acute Lymphoblastic Leukemia
Background: Methotrexate has an important role in treatment of acute leukemia. We measured methotrexate level in CSF and blood of children with acute lymphoblastic leukemia to determine complications and outcomes. Materials and Methods: One hundred and twenty patients (73 male, 47 female), with mean age at diagnosis of 6.1 years (11mo_15years) entered the study. Patients were divided into two...
متن کاملHigh dose of bolus iron vs. low dose of weekly infusion: bolusing high dose, a recipe for iron toxicity?
Sir, We read with interest the article by Kosch et al. w1x comparing the i.v. infusion of iron sucrose with iron gluconate in patients on haemodialysis. Although this study provides some direct comparative analysis between two forms of parenteral iron compounds, the implication that iron sucrose being a monthly bolus dose might be better than the more frequently, Nephrol Dial Transplant (2002) ...
متن کاملPharmacokinetics and toxicity of two schedules of high dose epirubicin.
Epirubicin, a stereoisomer of doxorubicin, is reported to have equal antitumor activity with lower cardiac and systemic toxicity. Recently the maximum tolerated dose of this drug has been revised upwards with reported increased response rates. However, the pharmacokinetics of epirubicin at high doses have never been reported. Accordingly, this study was designed to evaluate the pharmacokinetics...
متن کاملHigh dose ropivacaine-induced toxicity after infraclavicular block
Corresponding author: Po Soon Kang, M.D., Department of Anesthesiology and Pain Medicine, School of Medicine, Konyang University, 685, Gasuwon-dong, Seo-gu, Daejeon 302-718, Korea. Tel: 82-42-600-9316, Fax: 82-42-545-2132, E-mail: [email protected] This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.or...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
international journal of hematology-oncology and stem cell researchجلد ۵، شماره ۱، صفحات ۱۶-۱۹
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023